Share

Stool sample shows up cancer

accreditation

Using just a stool sample, doctors may be able to detect colon and many other cancers of the digestive tract including stomach, pancreatic, bile duct and oesophageal cancer, US researchers said.

They said the test, which detects genetic material shed from the surface of cancer cells, found nearly 70% of cancers present in a group of patients with assorted cancers of the digestive tract.

The test also accurately showed negative results in all 70 healthy patients they tested, Dr David Ahlquist of the Mayo Clinic in Minnesota told the Digestive Disease Week meeting in Chicago.

Researchers at Mayo designed the stool sample test as a non-invasive way to find colon cancer, but they now believe it could help detect many different types of cancers of the digestive tract. "It's very exciting to see this level of sensitivity for digestive cancer detection in our first look at this test application," Ahlquist said.

How the study was done
The test looks for evidence of DNA changes shed from the lining of the colon and rectum. Cells from the surface of cancerous tumours and precancerous polyps show recognizable DNA changes or markers.

Several of these DNA markers have been identified and can be isolated in stool samples from people with colon and rectal tumours.

For the study, the team tested 70 patients with various cancers of the digestive tract, including colon, throat, oesophagus, stomach, pancreatic, bile duct, gallbladder and small bowel to see if gene mutations could be found in stool samples. They also used the test on 70 healthy patients.

The stool sample test found 65% of oesophageal cancers, 62% of pancreatic cancers and 75% of bile duct and gallbladder cancers. And it found 100% of both stomach and colorectal cancers. The test worked equally well on early and late-stage cancers.

"Historically, we've approached cancer screening one organ at a time," Ahlquist said, but he said stool DNA test could open the door to early detection of cancers above the colon which are currently not screened. Both Ahlquist and Mayo have a financial interest in the test.

Gastrointestinal cancers account for about one in four cancer deaths in the United States, but currently, patients are only routinely screened for colon cancer. – (Reuters Health, June 2009)

Read more:
Immune therapies treat cancer
Man bets on his own life, wins

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE